Biotechnology

Insilico Details AI-Designed, Cancer-Fighting PROTAC Ta...

In preclinical studies, D16-M1P2 showed consistent potency in CCNE1-amplified br...

New Monoclonal Antibody Shows Promise in Immune Thrombo...

In a Phase III clinical trial, over half of patients who received a limited cour...

Mirum Pharma and Bluejay Therapeutics Deal Seen as Boos...

Brelovitug in Phase II trials demonstrated strong antiviral activity in Hepatiti...

Implant Delivers Patterned Optogenetic Stimulation, Gen...

A wireless, flexible, micro-LED array delivers patterned optogenetic stimulation...

Neurodegeneration Driven by Ferroptosis Resulting from ...

Researchers linked a mutation in GPX4 with ferroptotic neurodegeneration and Alz...

Drug Discovery Innovation: Target Deconvolution and Tra...

In this GEN webinar, our expert speakers will explore cutting-edge drug discover...

NeurIPS 2025: Altos Labs Wins Generalist Prize at Arc’s...

The inaugural competition surprisingly awarded two $100,000 grand prizes to addr...

Meet the Next Generation of Benchtop Sequencing Systems

With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Ad...

Gut Microbe Molecule Reduces Inflammation and Improves ...

Gut-microbe–derived trimethylamine (TMA) blocks a key immune protein, reducing i...

StockWatch: Cosmo Surges 40% on Baldness Candidate’s Ph...

Cosmo Pharmaceuticals attracted welcome attention from investors and other marke...

Antibody Blocks Triple-Negative Breast Cancer Growth an...

Preclinical study in cells and mouse models showed that an antibody targeting SF...

The ads that sell the sizzle of genetic trait discrimin...

One day this fall, I watched an electronic sign outside the Broadway-Lafayette s...

Lung Organoids, Autism and Sarcopenia Insights in Mice,...

In this episode of GEN's Touching Base, we discuss lung organoid manufacturing, ...

Muscle Stem Cells Bolstered by ECM Protein Tenascin-C

Protein composition of muscular extracellular matrix impacts the function of mus...

PACE panel urges incentives for exciting new GTT drugs

Luke Rosen had hoped a new treatment would slow the progression of his daughter’...

Ahead of BIO IP Conference, research highlights why bio...

Venture capital funding for life sciences startups plummeted after legal changes...